Boer H R, Gal P
Clin Pediatr (Phila). 1982 Aug;21(8):453-7. doi: 10.1177/000992288202100801.
A nationwide survey of neonatologists and pediatric neurologists was conducted to ascertain their methods of evaluating and managing neonatal seizures. Of the sampled 750 physicians, 284 (38%) responded to the single mailing. Most respondents use a routine for seizure workup which includes glucose, calcium and electrolyte determinations, and a lumbar puncture. On the other hand, there was a great variation in the use of an EEG, CT scan skull x-ray, and a drug and metabolic screen. Phenobarbital was the initial drug of choice and phenytoin usually the second drug. Neurologists used higher loading doses for phenobarbital and phenytoin. Most physicians monitored blood levels to adjust maintenance doses. Drug therapy was usually continued for two months to one year after seizure control. Criteria for discontinuation were often arbitrary but included a normal electroencephalogram and the absence of seizures. The results demonstrate a lack of consensus in the evaluation and management of neonates with seizures.
开展了一项针对新生儿科医生和儿科神经科医生的全国性调查,以确定他们评估和处理新生儿惊厥的方法。在抽取的750名医生中,有284名(38%)回复了第一次邮件。大多数受访者对惊厥检查采用常规方法,包括测定血糖、钙和电解质,以及进行腰椎穿刺。另一方面,脑电图、头颅CT扫描、颅骨X光检查以及药物和代谢筛查的使用存在很大差异。苯巴比妥是首选的初始药物,苯妥英通常作为第二种药物。神经科医生使用更高的苯巴比妥和苯妥英负荷剂量。大多数医生监测血药浓度以调整维持剂量。惊厥控制后,药物治疗通常持续两到一年。停药标准通常很随意,但包括脑电图正常和无惊厥发作。结果表明,在新生儿惊厥的评估和处理方面缺乏共识。